First Horizon Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
101,578
-2,140
| -2% | -$228K | 0.29% | 106 |
|
|
2025
Q1 | $11.6M | Sell |
103,718
-187,560
| -64% | -$19.4M | 0.33% | 95 |
|
|
2024
Q4 | $26.9M | Buy |
291,278
+16,591
| +6% | +$1.49M | 0.75% | 34 |
|
|
2024
Q3 | $23M | Buy |
274,687
+20,312
| +8% | +$1.55M | 0.64% | 45 |
|
|
2024
Q2 | $17.5M | Buy |
254,375
+7,260
| +3% | +$484K | 0.53% | 63 |
|
|
2024
Q1 | $18.1M | Buy |
247,115
+2,536
| +1% | +$195K | 0.56% | 58 |
|
|
2023
Q4 | $19.8M | Sell |
244,579
-2,929
| -1% | -$228K | 0.66% | 44 |
|
|
2023
Q3 | $18.5M | Buy |
247,508
+2,144
| +0.9% | +$165K | 0.67% | 45 |
|
|
2023
Q2 | $18.9M | Sell |
245,364
-3,466
| -1% | -$276K | 0.66% | 43 |
|
|
2023
Q1 | $20.6M | Sell |
248,830
-10,000
| -4% | -$828K | 0.74% | 37 |
|
|
2022
Q4 | $22.2M | Sell |
258,830
-9,633
| -4% | -$763K | 0.82% | 31 |
|
|
2022
Q3 | $16.6M | Sell |
268,463
-3,594
| -1% | -$227K | 0.66% | 48 |
|
|
2022
Q2 | $16.8M | Buy |
272,057
+184,741
| +212% | +$11.4M | 0.6% | 53 |
|
|
2022
Q1 | $5.19M | Sell |
87,316
-140,755
| -62% | -$9M | 0.28% | 107 |
|
|
2021
Q4 | $16.6M | Buy |
228,071
+5,133
| +2% | +$354K | 0.5% | 57 |
|
|
2021
Q3 | $15.6M | Buy |
222,938
+20,420
| +10% | +$1.43M | 0.51% | 59 |
|
|
2021
Q2 | $13.9M | Buy |
202,518
+12,993
| +7% | +$868K | 0.75% | 40 |
|
|
2021
Q1 | $12.2M | Buy |
189,525
+13,334
| +8% | +$860K | 0.71% | 42 |
|
|
2020
Q4 | $10.3M | Buy |
176,191
+7,637
| +5% | +$461K | 0.69% | 43 |
|
|
2020
Q3 | $10.6M | Buy |
168,554
+4,307
| +3% | +$299K | 0.8% | 33 |
|
|
2020
Q2 | $12.6M | Buy |
164,247
+3,401
| +2% | +$261K | 1% | 26 |
|
|
2020
Q1 | $12M | Buy |
160,846
+16,782
| +12% | +$1.16M | 1.12% | 23 |
|
|
2019
Q4 | $9.36M | Sell |
144,064
-4,098
| -3% | -$267K | 0.69% | 38 |
|
|
2019
Q3 | $9.39M | Buy |
148,162
+3,663
| +3% | +$239K | 0.73% | 38 |
|
|
2019
Q2 | $9.76M | Buy |
144,499
+7,276
| +5% | +$479K | 0.75% | 36 |
|
|
2019
Q1 | $8.92M | Buy |
137,223
+67,686
| +97% | +$4.5M | 0.71% | 38 |
|
|
2018
Q4 | $4.35M | Sell |
69,537
-4,139
| -6% | -$289K | 0.39% | 65 |
|
|
2018
Q3 | $5.69M | Buy |
73,676
+456
| +0.6% | +$34.4K | 0.44% | 68 |
|
|
2018
Q2 | $5.19M | Buy |
73,220
+973
| +1% | +$68.7K | 0.44% | 70 |
|
|
2018
Q1 | $5.44M | Sell |
72,247
-522
| -0.7% | -$41.5K | 0.53% | 59 |
|
|
2017
Q4 | $5.33M | Sell |
72,769
-2,627
| -3% | -$199K | 0.51% | 68 |
|
|
2017
Q3 | $6.15M | Sell |
75,396
-891
| -1% | -$68.1K | 0.63% | 50 |
|
|
2017
Q2 | $5.45M | Buy |
76,287
+5,080
| +7% | +$338K | 0.59% | 57 |
|
|
2017
Q1 | $4.84M | Buy |
71,207
+6,931
| +11% | +$487K | 0.55% | 61 |
|
|
2016
Q4 | $5.03M | Hold |
64,276
| – | – | 0.64% | 52 |
|
|
2016
Q3 | $5.03M | Buy |
64,276
+6,895
| +12% | +$560K | 0.64% | 52 |
|
|
2016
Q2 | $4.79M | Sell |
57,381
-4,764
| -8% | -$423K | 0.65% | 54 |
|
|
2016
Q1 | $5.61M | Buy |
62,145
+5,946
| +11% | +$536K | 0.63% | 51 |
|
|
2015
Q4 | $5.68M | Sell |
56,199
-1,762
| -3% | -$183K | 1.01% | 20 |
|
|
2015
Q3 | $5.69M | Buy |
57,961
+849
| +1% | +$94.3K | 0.88% | 28 |
|
|
2015
Q2 | $6.69M | Sell |
57,112
-1,592
| -3% | -$174K | 0.97% | 20 |
|
|
2015
Q1 | $5.78M | Sell |
58,704
-358
| -0.6% | -$36.4K | 0.84% | 31 |
|
|
2014
Q4 | $5.57M | Sell |
59,062
-591
| -1% | -$61.1K | 0.86% | 25 |
|
|
2014
Q3 | $6.35M | Sell |
59,653
-15,794
| -21% | -$1.55M | 0.99% | 19 |
|
|
2014
Q2 | $6.3M | Buy |
75,447
+8,960
| +13% | +$697K | 0.91% | 19 |
|
|
2014
Q1 | $4.71M | Buy |
66,487
+5,777
| +10% | +$453K | 0.66% | 25 |
|
|
2013
Q4 | $4.43M | Sell |
60,710
-167
| -0.3% | -$11.6K | 0.66% | 23 |
|
|
2013
Q3 | $3.83M | Buy |
60,877
+58,724
| +2,728% | +$3.51M | 0.62% | 28 |
|
|
2013
Q2 | $110K | Buy |
+2,153
| New | +$112K | 0.06% | 116 |
|
Other funds holding GILD
First Horizon Advisors's GILD Position: Q2 2025 in Review
First Horizon Advisors reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2025, selling an estimated $228K and leaving 101,578 shares worth $11.3M. The position accounts for 0.29% of the portfolio, ranked #106.
First Horizon Advisors first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $26.9M in Q4 2024. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- First Horizon Advisors held 101,578 shares of Gilead Sciences worth $11.3M as of Q2 2025.
- First Horizon Advisors sold 2,140 Gilead Sciences shares in Q2 2025, an estimated $228K.
- Gilead Sciences made up 0.29% of First Horizon Advisors's portfolio in Q2 2025, its #106 holding.
- First Horizon Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Gilead Sciences position peaked at $26.9M in Q4 2024.
- 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.